Opportunities in the International Consortium of Vascular Registries

Paulo Eduardo Ocke Reis

Published Date: 2018-12-17
DOI10.21767/2573-4482.18.03.24

Paulo Eduardo Ocke Reis*

Department of Specialized and General Surgery, Fluminense Federal University, Rio de Janeiro, Brazil

*Corresponding Author:
Paulo Eduardo Ocke Reis
Department of Specialized and General Surgery
Fluminense Federal University, Brazil
Tel: +55 21 2629-5000
E-mail: vascular@pauloocke.com.br

Received Date: December 01, 2018; Accepted Date: December 10, 2018; Published Date: December 17, 2018

Citation: Ocke Reis PE (2018) Opportunities in the International Consortium of Vascular Registries. J Vasc Endovasc Therapy. 3:24.

Visit for more related articles at Journal of Vascular and Endovascular Therapy

Editorial

It is difficult for vascular surgeons to recognize patterns associated with bad outcomes because they occur infrequently even in a busy practice. This makes quality improvement difficult and suggests the need for collaborative registries that can analyze thousands of patients to discern and incent best practices. Hertzer and colleagues first demonstrated the feasibility of a regional vascular registry in 1979 and emphasized that we must measure our performance in order to improve it [1]. By the 1990’s, several European vascular registries were established and were organized as the VASCUNET collaboration of registries under the European Society of Vascular and Endovascular Surgery in 1997 [2]. In 2002, the first US regional vascular quality improvement registry was started in New England [3], and this expanded to become the Vascular Quality Initiative (VQI) of the Society for Vascular Surgery in 2011 [4].

Benefiting from this rich background, the International Consortium of Vascular Registries (ICVR) was organized as a global collaboration of 13 national registries from VASCUNET and VQI [5]. It has infrastructure support from the Medical Device Epidemiology Network (MDEpiNet) [6], a US based public private partnership sponsored by the FDA to promote the use of real-world evidence for medical device evaluation. The ICVR aims to improve the quality of vascular care by exchanging information among many countries by analyzing and reporting on variation in treatment type, patient selection and device performance. ICVR meets biannually with representatives from Australia, Denmark, Finland, France, Germany, Hungary, Iceland, Japan, Netherlands, New Zealand, Spain, Sweden, Switzerland, United Kingdom and United States. Recent projects analysing>30,000 AAA and 60,000 carotid procedures showed substantial variation in treatment type and patient selection by country, with opportunity to reach more uniform care [7,8]. Current projects are focusing on outcome and device evaluation.

After attending the recent ICVR meeting in New York City, I am motivated to initiate a quality improvement registry in Brazil, and hope that other South American countries will follow. It can be challenging to start a national registry, but lessons from ICVR countries suggest that we start with limited data collection for 1-2 treatment types and expand this gradually. Surgeons are keenly interested in benchmark reports that anonymously compare their results with others, since all want to see what and how they can improve. It is my hope to launch this in several Brazilian centres in 2019 and invite all interested surgeons to contact me.

References

open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article

paper.io

agar io

wowcappadocia.com
cappadocia-hotels.com
caruscappadocia.com
brothersballoon.com
balloon-rides.net

wormax io